Skip to main content
Screener/Healthcare/Biotechnology

ACRV Acrivon Therapeutics, Inc. Common Stock

NASDAQ
$1.53+0.04 (+2.33%)
$1.20
$3.56
$1.48
$1.54
EPS (TTM)$-2.00
P/E Ratio-0.94
Dividend Yield
Market Cap$52.7M
Volume178K
Prev Close$1.50
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$19.0M$-0.49
Q4 '25$0-$19.0M$-0.49
Q3 '25$0-$18.2M$-0.47
Q2 '25$0-$21.0M$-0.55
Q1 '25$0-$19.7M$-0.51
Q4 '24$0-$22.8M$-0.60
Q3 '24$0-$22.4M$-0.59
Q2 '24$0-$18.8M$-0.52
Get Your Daily Market Recap